Published in:
Open Access 01-12-2016 | Erratum
Erratum to: JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
Published in: Breast Cancer Research | Issue 1/2016
Login to get accessExcerpt
In the original publication of the article [1], we noticed an error to Table 2. The numbers for each ARHI staining in the subtypes of JMJD2A were mistakenly copied from another molecular which we were simultaneously working on. This mistake went unfortunately unnoticed in the thereafter review and proofreading processes. The Table 2 shown in this erratum is the correct representation of the data from this study. The authors apologize for this error.
Table 2
Association between JMJD2A expression and clinicopathological parameters in 155 cases of breast cancers
|
Total
|
JMJD2A
|
P -value
|
Correlation coefficient
|
||||
|---|---|---|---|---|---|---|---|
|
0(-) n = 11
|
1(+) n = 56
|
2(++) n = 53
|
3(+++) n = 35
|
||||
|
ERα
|
|||||||
|
Negative
|
52
|
4
|
18
|
17
|
13
|
0.778
|
-0.023
|
|
positive
|
103
|
7
|
38
|
36
|
22
|
||
|
PR
|
|||||||
|
Negative
|
77
|
7
|
22
|
26
|
22
|
0.147
|
-0.117
|
|
positive
|
78
|
4
|
34
|
27
|
13
|
||
|
HER2
|
|||||||
|
Negative
|
7
|
0
|
3
|
2
|
2
|
0.742
|
-0.027
|
|
Positive
|
148
|
11
|
53
|
51
|
33
|
||
|
ARHI
|
|||||||
|
Negative
|
63
|
3
|
18
|
23
|
19
|
0.021*
|
-0.185
|
|
Positive
|
92
|
8
|
38
|
30
|
16
|
||